477 related articles for article (PubMed ID: 33156926)
1. The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.
Mapperley C; van de Lagemaat LN; Lawson H; Tavosanis A; Paris J; Campos J; Wotherspoon D; Durko J; Sarapuu A; Choe J; Ivanova I; Krause DS; von Kriegsheim A; Much C; Morgan M; Gregory RI; Mead AJ; O'Carroll D; Kranc KR
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33156926
[TBL] [Abstract][Full Text] [Related]
2. Suppression of m
Li Z; Qian P; Shao W; Shi H; He XC; Gogol M; Yu Z; Wang Y; Qi M; Zhu Y; Perry JM; Zhang K; Tao F; Zhou K; Hu D; Han Y; Zhao C; Alexander R; Xu H; Chen S; Peak A; Hall K; Peterson M; Perera A; Haug JS; Parmely T; Li H; Shen B; Zeitlinger J; He C; Li L
Cell Res; 2018 Sep; 28(9):904-917. PubMed ID: 30065315
[TBL] [Abstract][Full Text] [Related]
3. Targeting the RNA m
Paris J; Morgan M; Campos J; Spencer GJ; Shmakova A; Ivanova I; Mapperley C; Lawson H; Wotherspoon DA; Sepulveda C; Vukovic M; Allen L; Sarapuu A; Tavosanis A; Guitart AV; Villacreces A; Much C; Choe J; Azar A; van de Lagemaat LN; Vernimmen D; Nehme A; Mazurier F; Somervaille TCP; Gregory RI; O'Carroll D; Kranc KR
Cell Stem Cell; 2019 Jul; 25(1):137-148.e6. PubMed ID: 31031138
[TBL] [Abstract][Full Text] [Related]
4. m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response.
Yu R; Li Q; Feng Z; Cai L; Xu Q
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875984
[TBL] [Abstract][Full Text] [Related]
5. CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation.
Lawson H; van de Lagemaat LN; Barile M; Tavosanis A; Durko J; Villacreces A; Bellani A; Mapperley C; Georges E; Martins-Costa C; Sepulveda C; Allen L; Campos J; Campbell KJ; O'Carroll D; Göttgens B; Cory S; Rodrigues NP; Guitart AV; Kranc KR
Stem Cell Reports; 2021 Nov; 16(11):2784-2797. PubMed ID: 34715054
[TBL] [Abstract][Full Text] [Related]
6. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
7. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts.
Imam H; Kim GW; Mir SA; Khan M; Siddiqui A
PLoS Pathog; 2020 Feb; 16(2):e1008338. PubMed ID: 32059034
[TBL] [Abstract][Full Text] [Related]
8. m
Qi M; Sun H; Guo Y; Zhou Y; Gu X; Jin J; Chen X; Wang F; Ma H; Guo X; Chen H; Shen B
Cell Prolif; 2022 Jan; 55(1):e13164. PubMed ID: 34850470
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Hou G; Zhao X; Li L; Yang Q; Liu X; Huang C; Lu R; Chen R; Wang Y; Jiang B; Yu J
Nucleic Acids Res; 2021 Mar; 49(5):2859-2877. PubMed ID: 33577677
[TBL] [Abstract][Full Text] [Related]
10. The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.
Ma S; Yan J; Barr T; Zhang J; Chen Z; Wang LS; Sun JC; Chen J; Caligiuri MA; Yu J
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34160549
[TBL] [Abstract][Full Text] [Related]
11. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus X Protein Expression Is Tightly Regulated by N6-Methyladenosine Modification of Its mRNA.
Kim GW; Siddiqui A
J Virol; 2022 Feb; 96(4):e0165521. PubMed ID: 34851655
[TBL] [Abstract][Full Text] [Related]
13. The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.
Dixit D; Prager BC; Gimple RC; Poh HX; Wang Y; Wu Q; Qiu Z; Kidwell RL; Kim LJY; Xie Q; Vitting-Seerup K; Bhargava S; Dong Z; Jiang L; Zhu Z; Hamerlik P; Jaffrey SR; Zhao JC; Wang X; Rich JN
Cancer Discov; 2021 Feb; 11(2):480-499. PubMed ID: 33023892
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence.
Luo Y; Li L; Zou P; Wang J; Shao L; Zhou D; Liu L
Transplantation; 2014 Jan; 97(1):20-9. PubMed ID: 24092377
[TBL] [Abstract][Full Text] [Related]
15. Understanding YTHDF2-mediated mRNA degradation by m6A-BERT-Deg.
Zhang TH; Jo S; Zhang M; Wang K; Gao SJ; Huang Y
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38622358
[TBL] [Abstract][Full Text] [Related]
16. YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators.
Fei Q; Zou Z; Roundtree IA; Sun HL; He C
PLoS Biol; 2020 Apr; 18(4):e3000664. PubMed ID: 32267835
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cells lacking Ott1 display aspects associated with aging and are unable to maintain quiescence during proliferative stress.
Xiao N; Jani K; Morgan K; Okabe R; Cullen DE; Jesneck JL; Raffel GD
Blood; 2012 May; 119(21):4898-907. PubMed ID: 22490678
[TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine modification and the YTHDF2 reader protein play cell type specific roles in lytic viral gene expression during Kaposi's sarcoma-associated herpesvirus infection.
Hesser CR; Karijolich J; Dominissini D; He C; Glaunsinger BA
PLoS Pathog; 2018 Apr; 14(4):e1006995. PubMed ID: 29659627
[TBL] [Abstract][Full Text] [Related]
19. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
[TBL] [Abstract][Full Text] [Related]
20. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
